25 June 2015 - Deborah Wilkes
Archived
Pfizer is investing US$95 million in a new Chinese production facility to meet "growing demand" for its Consumer Healthcare brands in China and the Asia-Pacific region.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.